Skip to main content
NCBI home page
Medline Book to support NIHPA logoLink to Medline Book to support NIHPA
. 2022;2453:585–603. doi: 10.1007/978-1-0716-2115-8_27

Purpose-Built Immunoinformatics for BcR IG/TR Repertoire Data Analysis.

Chrysi Galigalidou, Laura Zaragoza-Infante, Anastasia Chatzidimitriou, Kostas Stamatopoulos, Fotis Psomopoulos, Andreas Agathangelidis
PMCID: PMC9761556  PMID: 35622343

Abstract

The study of antigen receptor gene repertoires using next-generation sequencing (NGS) technologies has disclosed an unprecedented depth of complexity, requiring novel computational and analytical solutions. Several bioinformatics workflows have been developed to this end, including the T-cell receptor/immunoglobulin profiler (TRIP), a web application implemented in R shiny, specifically designed for the purposes of comprehensive repertoire analysis, which is the focus of this chapter. TRIP has the potential to perform robust immunoprofiling analysis through the extraction and processing of the IMGT/HighV-Quest output, via a series of functions, ensuring the analysis of high-quality, biologically relevant data through a multilevel process of data filtering. Subsequently, it provides in-depth analysis of antigen receptor gene rearrangements, including (a) clonality assessment; (b) extraction of variable (V), diversity (D), and joining (J) gene repertoires; (c) CDR3 characterization at both the nucleotide and amino acid level; and (d) somatic hypermutation analysis, in the case of immunoglobulin gene rearrangements. Relevant to mention, TRIP enables a high level of customization through the integration of various options in key aspects of the analysis, such as clonotype definition and computation, hence allowing for flexibility without compromising on accuracy.

Full text of this article can be found in Bookshelf.

References

  1. Rawstron AC, Fazi C, Agathangelidis A et al (2016) A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European research initiative on CLL study. Leukemia 30(4):929–936. https://doi.org/10.1038/leu.2015.313 doi: 10.1038/leu.2015.313. [DOI] [PMC free article] [PubMed]
  2. Rodriguez-Vicente AE, Bikos V, Hernandez-Sanchez M et al (2017) Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons. Oncotarget 8(41):71234–71248. https://doi.org/10.18632/oncotarget.19525 doi: 10.18632/oncotarget.19525. [DOI] [PMC free article] [PubMed]
  3. Bolotin DA, Shugay M, Mamedov IZ et al (2013) MiTCR: software for T-cell receptor sequencing data analysis. Nat Methods 10(9):813–814. https://doi.org/10.1038/nmeth.2555 doi: 10.1038/nmeth.2555. [DOI] [PubMed]
  4. Kuchenbecker L, Nienen M, Hecht J et al (2015) IMSEQ--a fast and error aware approach to immunogenetic sequence analysis. Bioinformatics 31(18):2963–2971. https://doi.org/10.1093/bioinformatics/btv309 doi: 10.1093/bioinformatics/btv309. [DOI] [PubMed]
  5. Thomas N, Heather J, Ndifon W et al (2013) Decombinator: a tool for fast, efficient gene assignment in T-cell receptor sequences using a finite state machine. Bioinformatics 29(5):542–550. https://doi.org/10.1093/bioinformatics/btt004 doi: 10.1093/bioinformatics/btt004. [DOI] [PubMed]
  6. Yang X, Liu D, Lv N et al (2015) TCRklass: a new K-string-based algorithm for human and mouse TCR repertoire characterization. J Immunol 194(1):446–454. https://doi.org/10.4049/jimmunol.1400711 doi: 10.4049/jimmunol.1400711. [DOI] [PubMed]
  7. Aouinti S, Giudicelli V, Duroux P et al (2016) IMGT/StatClonotype for pairwise evaluation and visualization of NGS IG and TR IMGT Clonotype (AA) diversity or expression from IMGT/HighV-QUEST. Front Immunol 7:339. https://doi.org/10.3389/fimmu.2016.00339 doi: 10.3389/fimmu.2016.00339. [DOI] [PMC free article] [PubMed]
  8. Aouinti S, Malouche D, Giudicelli V et al (2015) IMGT/HighV-QUEST statistical significance of IMGT Clonotype (AA) diversity per gene for standardized comparisons of next generation sequencing Immunoprofiles of immunoglobulins and T cell receptors. PLoS One 10(11):e0142353. https://doi.org/10.1371/journal.pone.0142353 doi: 10.1371/journal.pone.0142353. [DOI] [PMC free article] [PubMed]
  9. Bolotin DA, Poslavsky S, Mitrophanov I et al (2015) MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods 12(5):380–381. https://doi.org/10.1038/nmeth.3364 doi: 10.1038/nmeth.3364. [DOI] [PubMed]
  10. Duez M, Giraud M, Herbert R et al (2016) Vidjil: a web platform for analysis of high-throughput repertoire sequencing. PLoS One 11(11):e0166126. https://doi.org/10.1371/journal.pone.0166126 doi: 10.1371/journal.pone.0166126. [DOI] [PMC free article] [PubMed]
  11. Bystry V, Reigl T, Krejci A et al (2017) ARResT/interrogate: an interactive immunoprofiler for IG/TR NGS data. Bioinformatics 33(3):435–437. https://doi.org/10.1093/bioinformatics/btw634 doi: 10.1093/bioinformatics/btw634. [DOI] [PubMed]
  12. Kotouza MT, Gemenetzi K, Galigalidou C et al (2020) TRIP - T cell receptor/immunoglobulin profiler. BMC Bioinformatics 21(1):422. https://doi.org/10.1186/s12859-020-03669-1 doi: 10.1186/s12859-020-03669-1. [DOI] [PMC free article] [PubMed]
  13. Gemenetzi K, Agathangelidis A, Sutton L-A et al (2018) Remarkable functional constraints on the antigen receptors of CLL stereotyped subset #2: high-throughput Immunogenetic evidence. Blood 132(Supplement 1):1839. https://doi.org/10.1182/blood-2018-99-119125 doi: 10.1182/blood-2018-99-119125. [DOI]
  14. Vardi A, Vlachonikola E, Mourati S et al (2019) High-throughput B-cell immunoprofiling at diagnosis and relapse offers further evidence of functional selection throughout the natural history of chronic lymphocytic leukemia. HemaSphere 3:512. https://doi.org/10.1097/01.hs9.0000562808.48237.52 doi: 10.1097/01.hs9.0000562808.48237.52. [DOI]
  15. Vardi A, Vlachonikola E, Papazoglou D et al (2020) T-cell dynamics in chronic lymphocytic leukemia under different treatment modalities. Clin Cancer Res 26(18):4958–4969. https://doi.org/10.1158/1078-0432.CCR-19-3827 doi: 10.1158/1078-0432.CCR-19-3827. [DOI] [PubMed]
  16. Vlachonikola E, Vardi A, Kastritis E et al (2018) Longitudinal T cell Immunoprofiling of patients with relapsed and/or refractory myeloma who receive Daratumumab monotherapy: a subanalysis of a phase 2 study (the REBUILD study). Blood 134(Supplement 13167):3167. https://doi.org/10.1182/blood-2019-124655 doi: 10.1182/blood-2019-124655. [DOI]
  17. Galigalidou C, Papadopoulou A, Stalika E et al (2018) High-throughput T cell receptor (TR) repertoire analysis of virus-specific T cells: implications for T cell immunotherapy and viral infection risk stratification. Blood 132(Supplement 1):2057. https://doi.org/10.1182/blood-2018-99-118851 doi: 10.1182/blood-2018-99-118851. [DOI]
  18. Gemenetzi K, Stalika E, Agathangelidis A et al (2018) Evidence for epitope-specific T cell responses in HIV-associated non neoplastic lymphadenopathy: High-Throughput Immunogenetic Evidence. Blood 132(Supplement 1):1117. https://doi.org/10.1182/blood-2018-99-118975 doi: 10.1182/blood-2018-99-118975. [DOI]
  19. Lefranc MP, Giudicelli V, Duroux P et al (2015) IMGT(R), the international ImMunoGeneTics information system(R) 25 years on. Nucleic Acids Res 43(Database issue):D413–D422. https://doi.org/10.1093/nar/gku1056 doi: 10.1093/nar/gku1056. [DOI] [PMC free article] [PubMed]
  20. Li S, Lefranc MP, Miles JJ et al (2013) IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nat Commun 4:2333. https://doi.org/10.1038/ncomms3333 doi: 10.1038/ncomms3333. [DOI] [PMC free article] [PubMed]
  21. Chiorazzi N, Stevenson FK (2020) Celebrating 20 years of IGHV mutation analysis in CLL. HemaSphere 4(1):e334. https://doi.org/10.1097/HS9.0000000000000334 doi: 10.1097/HS9.0000000000000334. [DOI] [PMC free article] [PubMed]

RESOURCES